In a few weeks’ time, we learn who will be awarded the Nobel Prizes for 2021. As we have previously […]
In a few weeks’ time, we learn who will be awarded the Nobel Prizes for 2021. As we have previously […]
In a few weeks’ time, we learn who will be awarded the Nobel Prizes for 2021. As we have previously […]
Judging by their marketing, companies are gearing up for widespread adoption of their artificial intelligence (AI) algorithms by breast screening […]
NeoLogica, founded in 2002 by a small group of engineers, specializes in the design and development of advanced software solutions […]
Six years ago, we reviewed a paper published in The Lancet by the Japan Strategic Anti-Cancer Randomized Trial (J-START) in which the […]
Ten years ago, on 15 August 2011, we posted a blog on our website entitled “To screen or not to screen? That […]
There is an aphorism in clinical medicine – “When you hear hoofbeats, think of horses not zebras” – which means young doctors […]
Four years ago, we contributed a blog entitled “From land mines to breast cancer” in which we described a system from UK […]
Two weeks ago, The New York Times published an article entitled “Whatever happened to IBM’s Watson?” In 2011, the company’s supercomputer beat […]
We are all familiar with the aphorism, “Publish or perish,” challenging academics that unless they publish in reputable journals their […]
For the past week, two regions in South Africa have been engulfed in violence following the arrest and incarceration of our former […]